Page last updated: 2024-08-21

alpha-aminopyridine and Cancer of Pituitary

alpha-aminopyridine has been researched along with Cancer of Pituitary in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19903 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (33.33)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Bueno, AC; da Silva JĂșnior, RMP; de Castro, M; Martins, CS; Oliveira, HA; Pugliesi, RS1
Auriemma, RS; Cappabianca, P; Cavallo, LM; Colao, A; De Martino, MC; Di Cera, M; Frio, F; Grasso, LFS; Patalano, R; Pivonello, C; Pivonello, R; Solari, D; Vitulli, F1
Auger, C; Chanal, M; Chevallier, P; Fonteneau, G; Honnorat, J; Jouanneau, E; Lucia, K; Monteserin Garcia, JL; Rachwan, A; Raverot, G; Raverot, V; Theodoropoulou, M; Trouillas, J1
Barker, J; Dufy, B1
Gautvik, KM; Haug, E; Sand, O1
Rogawski, MA1

Other Studies

6 other study(ies) available for alpha-aminopyridine and Cancer of Pituitary

ArticleYear
PI3K inhibition by BKM120 results in anti-proliferative effects on corticotroph tumor cells.
    Journal of endocrinological investigation, 2022, Volume: 45, Issue:5

    Topics: Adenoma; Adrenocorticotropic Hormone; Aminopyridines; Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Corticotrophs; Humans; Mice; Morpholines; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Pituitary ACTH Hypersecretion; Pituitary Neoplasms; Proto-Oncogene Proteins c-akt

2022
Effect of combined treatment with a pan-PI3K inhibitor or an isoform-specific PI3K inhibitor and everolimus on cell proliferation in GH-secreting pituitary tumour in an experimental setting.
    Endocrine, 2018, Volume: 62, Issue:3

    Topics: Aminopyridines; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Enzyme Inhibitors; Everolimus; Morpholines; Phosphoinositide-3 Kinase Inhibitors; Pituitary Neoplasms; Rats; Signal Transduction; Thiazoles

2018
Differential Effects of PI3K and Dual PI3K/mTOR Inhibition in Rat Prolactin-Secreting Pituitary Tumors.
    Molecular cancer therapeutics, 2016, Volume: 15, Issue:6

    Topics: Aminopyridines; Animals; Cell Cycle Proteins; Cell Proliferation; Cell Survival; Humans; Imidazoles; Morpholines; Phosphatidylinositol 3-Kinases; Phosphorylation; Pituitary Neoplasms; Prolactin; Proto-Oncogene Proteins c-akt; Quinolines; Rats; Signal Transduction; TOR Serine-Threonine Kinases; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2016
[Properties of membrane ionic currents in pituitary clone cells].
    Comptes rendus des seances de la Societe de biologie et de ses filiales, 1983, Volume: 177, Issue:2

    Topics: 4-Aminopyridine; Aminopyridines; Animals; Cell Line; Clone Cells; Cobalt; Electrophysiology; Pituitary Neoplasms; Rats; Tetraethylammonium; Tetraethylammonium Compounds

1983
Effects of thyroliberin and 4-aminopyridine on action potentials and prolactin release and synthesis in rat pituitary cells in culture.
    Acta physiologica Scandinavica, 1980, Volume: 108, Issue:3

    Topics: Action Potentials; Aminopyridines; Animals; Cell Line; In Vitro Techniques; Pituitary Neoplasms; Prolactin; Rats; Thyrotropin-Releasing Hormone

1980
Transient outward current (IA) in clonal anterior pituitary cells: blockade by aminopyridine analogs.
    Naunyn-Schmiedeberg's archives of pharmacology, 1988, Volume: 338, Issue:2

    Topics: Aminopyridines; Animals; Clone Cells; Kinetics; Membrane Potentials; Pituitary Gland, Anterior; Pituitary Neoplasms; Potassium Channels; Structure-Activity Relationship; Tumor Cells, Cultured

1988